Learn More
Medchemexpress LLC Fedratinib hydrochloride hydrate | 1374744-69-0 | MFCD28137677 | 99.9% | 615.62 g·mol⁻¹ | C27H40Cl2N6O4S | 200 MG

Supplier: Medchemexpress LLC HY10409A200MG
Fedratinib (hydrochloride hydrate) is a potent, selective, ATP-competitive JAK2 inhibitor supplied as a solid for research into myeloproliferative disorders and cancer biology. The compound is well characterized chemically, with a defined formula and molecular weight suitable for biochemical and cellular studies.
- Potent, selective JAK2 inhibitor with low-nanomolar potency.
- High purity (>99.9%) confirmed by certificate of analysis.
- Molecular weight 615.62 g·mol⁻¹ and formula C27H40Cl2N6O4S.
- Supplied as a white to yellow solid, suitable for handling and storage.
- Available in multiple pack sizes, including a 200 MG unit.
- Suitable for in vitro and in vivo research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.